Aurinia Pharmaceuticals Inc.
AUPH
$15.35
$0.171.12%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 443.02M | 378.52M | 397.94M | 351.51M | 315.05M |
| Total Receivables | 42.14M | 49.88M | 42.15M | 30.93M | 40.39M |
| Inventory | 45.15M | 46.41M | 45.69M | 44.79M | 46.50M |
| Prepaid Expenses | 10.53M | 4.12M | 5.75M | 11.11M | 6.58M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 481.00K | 1.32M | 433.00K | 401.00K | 453.00K |
| Total Current Assets | 541.32M | 480.24M | 491.97M | 438.74M | 408.97M |
|
|
|||||
| Total Current Assets | 541.32M | 480.24M | 491.97M | 438.74M | 408.97M |
| Net Property, Plant & Equipment | 68.53M | 73.15M | 79.57M | 84.80M | 89.45M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 3.38M | 3.59M | 3.76M | 3.90M | 4.05M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 179.03M | 167.01M | 176.29M | 93.00K | 93.00K |
| Total Assets | 792.26M | 724.00M | 751.59M | 527.53M | 502.56M |
|
|
|||||
| Total Accounts Payable | 1.74M | 2.66M | 3.31M | 2.21M | 3.31M |
| Total Accrued Expenses | 64.11M | 58.20M | 66.47M | 49.32M | 49.39M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 18.18M | 18.14M | 17.59M | 17.37M | 17.21M |
| Total Finance Division Other Current Liabilities | 15.86M | 7.56M | 6.35M | 7.32M | 8.35M |
| Total Other Current Liabilities | 15.86M | 7.56M | 6.35M | 7.32M | 8.35M |
| Total Current Liabilities | 99.89M | 86.56M | 93.72M | 76.22M | 78.27M |
|
|
|||||
| Total Current Liabilities | 99.89M | 86.56M | 93.72M | 76.22M | 78.27M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 45.95M | 50.50M | 57.22M | 60.85M | 64.62M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 31.55M | 19.32M | 19.31M | 24.69M | 24.38M |
| Total Liabilities | 177.40M | 156.37M | 170.26M | 161.76M | 167.26M |
|
|
|||||
| Common Stock & APIC | 1.19B | 1.18B | 1.23B | 1.23B | 1.23B |
| Retained Earnings | -577.60M | -615.01M | -649.37M | -860.16M | -891.71M |
| Treasury Stock & Other | -977.00K | -880.00K | -599.00K | -749.00K | -905.00K |
| Total Common Equity | 614.86M | 567.63M | 581.33M | 365.77M | 335.30M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 614.86M | 567.63M | 581.33M | 365.77M | 335.30M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 614.86M | 567.63M | 581.33M | 365.77M | 335.30M |
|
|
|||||